Melius initiates Constellation Energy stock with Buy rating on nuclear dominance

Constellation Energy (CEG) is experiencing heightened analyst interest following its Q2 2025 adjusted EPS beat of $1.91 against a $1.85 consensus and reaffirmed full-year guidance. Melius Research initiated coverage with a Buy rating and a $462 price target, emphasizing CEG's dominant position in U.S. carbon-free power generation and the strategic Calpine acquisition, while several other firms subsequently raised their price targets, reflecting a largely positive outlook despite InvestingPro data indicating potential overvaluation.

Analysis

Constellation Energy (CEG) is experiencing a wave of positive analyst sentiment, led by a new Buy rating and a $462 price target from Melius Research. This bullish outlook is predicated on the company's dominant position as the largest U.S. producer of carbon-free energy, generating approximately 10% of the nation's power and serving three-quarters of Fortune 500 companies. The pending Calpine acquisition is expected to further solidify this market leadership. The company's recent operational performance underpins this confidence, with Q2 2025 adjusted EPS of $1.91 beating the $1.85 consensus and a reaffirmation of its full-year guidance range of $8.90 to $9.60. This has triggered a series of price target increases from multiple firms, including BofA Securities ($374), BMO Capital ($375), and Raymond James ($393). However, a key counterpoint for consideration is the stock's valuation; despite the strong fundamentals, its 67% gain over the past year has led to data signals suggesting it may be overvalued, a sentiment partially reflected in Mizuho's Neutral rating and $335 price target.

Key Decisions for Investors

• Investors should weigh the strong fundamental case, driven by leadership in carbon-free energy and positive earnings momentum, against valuation concerns arising from the stock's 67% year-over-year appreciation.
• Monitor the successful closing and integration of the pending Calpine acquisition, as this is presented as a key catalyst for enhancing Constellation's market presence and future earnings power.
• Note the wide dispersion in analyst price targets, ranging from $335 to $462, which suggests a varied outlook on future upside and warrants a careful assessment of the risk/reward profile.
• Given the reaffirmed full-year guidance, future earnings reports will be critical to validate the current bullish narrative and justify the stock's premium valuation.